Semax and Selank are different synthetic peptides with overlapping early research histories, but they are not interchangeable products. Semax is an ACTH(4-10) analogue developed in Russia; Selank is a different heptapeptide, described in published research as an analogue of taftsin. Their research records cover specific laboratory and small human-study settings, while FDA status and a seller’s product label are separate questions.
Disclosure: Heads up, this page contains affiliate links. We may earn a commission when you buy through these links.
What is the difference between Semax and Selank?
Semax is the seven-amino-acid peptide Met-Glu-His-Phe-Pro-Gly-Pro. A developer review describes its design history and discusses attention, memory, and hypoxia-related research; those statements are the developers’ account of their work. Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro. A 2001 human-serum experiment reported that both peptides affected enkephalin-degrading enzymes in the test system, at different concentrations.
| Question | Semax | Selank |
|---|---|---|
| Peptide sequence | Met-Glu-His-Phe-Pro-Gly-Pro | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Research framing | ACTH(4-10) analogue | Taftsin analogue |
| Human study in this record | 30-person acute ischemic-stroke report | 52-participant functional-connectivity study included Selank, Semax, and placebo |
| Laboratory finding | Rat work examined BDNF and neurotrophin-gene expression | Human-serum enzyme experiment examined peptide activity |
The most useful starting point is to keep the chemical identity, the study setting, and any commercial product label separate.
What does the research actually cover?
The Semax clinical record in this collection includes a 30-patient stroke study involving people in the acute period after hemispheric ischemic stroke. In everyday terms, 30 participants is a small group in an acute ischemic-stroke study; it is not a general comparison of Semax for attention, tiredness, ADHD, dementia, or everyday cognitive goals.
Most Semax mechanism work here is preclinical. A rat basal-forebrain study measured increased BDNF protein after Semax, and another rat study measured changes in neurotrophin-related genes following cerebral ischemia. These findings describe what researchers measured in rats, not a result promised by a vial or nasal product.
For the direct comparison, a 2020 52-participant fMRI study measured resting-state functional connectivity before and after Semax, Selank, or placebo and reported both shared and distinct connectivity changes involving the amygdala and temporal cortex. That is the clearest head-to-head human study in this record. A separate rat experiment reported different behavior findings for Semax and Selank in a toxin-induced Parkinsonism model.
The human record is small, and it does not provide a basis for a Semax–Selank stack, an ADHD or dementia use, or a personal dosing or route plan.
Why is Semax not FDA approved, and is it banned?
Semax is not an FDA-approved drug in the United States. As Johns Hopkins explains, drug approval involves research on safety and effectiveness plus manufacturing and adverse-event requirements; a peptide’s name or research history is not drug approval.
“Not FDA approved” and “banned” are different ideas. FDA’s current bulk-substances page has entries for Semax and Selank acetate that discuss possible immunogenicity and peptide-related impurities in compounded products. The Semax entry says FDA has no, or limited, safety-related information for proposed routes of administration and lacks sufficient information to know whether the drug would cause harm if administered to humans; the Selank acetate entry says FDA lacks important information regarding safety issues raised by its administration to humans.
That record also explains why a nomination, a compounding discussion, and an approved drug should not be treated as the same thing. The FDA compounding overview explains that compounded drugs are not FDA-approved and are not reviewed before marketing in the same way as approved drugs.
Can Semax and Selank be taken together?
The 2020 fMRI study compared Semax, Selank, and placebo; it was not a combination study. A 2001 human-serum experiment and rat studies give researchers reasons to study biological activity, but they do not create a personal mixing, cycling, injection, oral-use, or nasal-spray plan.
If a question involves a symptom, a medication, seizure history, heart-rate concern, fatigue, hair changes, headache, diarrhea, or insomnia, the practical next step is a clinician who can assess that specific situation rather than an online peptide routine.
How do selected sellers label Semax and Adamax products?
Seller descriptions tell you what is being offered; they do not turn research-use material into an approved medicine. Prism Labs describes its Semax as a peptide for neuropeptide-signaling and neurotrophic-pathway research, sold in vials. Kylo Peptides says its catalog is for qualified laboratory and in-vitro research and not for human or veterinary use. Northline Labs describes Adamax as an adamantane-modified Semax-core research material and labels it not for human or veterinary use.
| Seller and item | What the seller says | Format or listed amount | Product Page |
|---|---|---|---|
| Prism Labs Semax | Research focused on neuropeptide signaling and neurotrophic pathways; batch COA available | Vial; 5 mg or 10 mg | Product Page |
| Kylo Peptides catalog | Kylo labels its catalog for laboratory and in-vitro research by qualified professionals | Product Page | |
| Northline Labs Adamax | Research-grade Semax analogue with N-acetylation and adamantyl modification; COA described as available | Lyophilized powder; 10 mg | Product Page |
Adamax should not be treated as a proven substitute for either Semax or Selank. Northline Labs’ description is the relevant product description here, while the Semax and Selank research above concerns those named peptides.
What do Semax products cost?
Prices shown October 28, 2026: Prism Labs listed its 5 mg Semax vial at $24.99 and its 10 mg vial at $35.99, with volume discounts described on its product page. The same page displayed a 15% first-order offer, bringing the displayed 10 mg selection to $30.59. Ask the seller whether the lot that will ship has lot-specific documentation; its published reports may cover past lots.
For a closer look at the label, price display, and buyer checks for that listing, see the Prism Labs Semax review. For a separate research-supplier overview, see the Kylo Peptides Semax review.
What should you check before ordering?
- Match the exact peptide name to the study you are reading; Semax, Selank, and Adamax are not the same compound.
- Read the seller’s intended-use label before putting an item in your cart.
- A COA describes the stated sample and test methods; ask whether its lot identifier matches the lot that will ship.
- For a personal legal, prescription, or sport-rule question, confirm the current requirement with the relevant state authority, prescriber, pharmacy, or sport body before acting.
- Ask the seller for the return terms and the lot-specific documentation that will apply to your order.
By HealthDataConsortium.org Research Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.
